ofloxacin and phenylalanine arginine beta-naphthylamide

ofloxacin has been researched along with phenylalanine arginine beta-naphthylamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blais, J; Chamberland, S; Cho, D; Fronko, R; Galazzo, J; Hecker, S; Hoshino, K; Ishida, H; Lee, A; Lee, M; Lee, VJ; Leger, R; Lomovskaya, O; Renau, T; Warren, MS; Watkins, W1
Coban, AY; Durupinar, B; Ekinci, B1
Izard, D; Mullié, C; Sonnet, P1

Other Studies

3 other study(ies) available for ofloxacin and phenylalanine arginine beta-naphthylamide

ArticleYear
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carrier Proteins; Cephalosporins; Dipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Levofloxacin; Magnetic Resonance Spectroscopy; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Pseudomonas aeruginosa

2001
A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
    Chemotherapy, 2004, Volume: 50, Issue:1

    Topics: Bacterial Outer Membrane Proteins; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa

2004
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections

2012